CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.
Yiquan XiongLan ShiLei LiWen YangHuiqiong ZhangXiangwang ZhaoNa ShenPublished in: Journal of translational medicine (2024)
We suggested that CDCA5 promoted progression of breast cancer via CDCA5/FOXM1/Wnt axis, CDCA5 might serve as a novel therapeutic target for breast cancer treatment.